Mesoblast Plans Small Trial After Second CRL For GVHD Cell Therapy

 
• By Joseph Haas
  
FDA Complete response stamp holder
Mesoblast is planning new trial after second FDA complete response • Source: Nielsen Hobbs; the Pink Sheet | Alamy image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Complete Response Letters

More from Product Reviews